Paradigm Biopharmaceuticals Ltd has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-422
6ix hasn’t read this filing yet.
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Paradigm to Proceed with Phase 3 Knee OA Trial
- Response to ASX Price Query
- 2024 Chairman Address and AGM Presentation
- Phase 3 Protocol Submission to US FDA
- Paradigm Investor Update
Later from Paradigm Biopharmaceuticals
- Successful Completion of $16M Placement for Phase 3
- PAR Capital Raising Presentation
- Paradigm Receives $6.3m R&D Tax Refund
- Quarterly Activities/Appendix 4C Cash Flow Report
- PAR Selects Advanced Clinical as CRO for Phase 3
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals